Click a link below to view the mailing archive as if it had been sent to you.
| 2012-10-31 12:00 | | Theravance's CEO Discusses Q3 2012 Results - Earnings Call Transcript and more... |
| 2012-10-31 00:00 | | Allergan Posts Flat Q3 Profit, Lifts Low End Of Earnings Outlook and more... |
| 2012-10-30 00:00 | | Titan Files NDA on Probuphine; Partner Waits and more... |
| 2012-10-29 12:00 | | GSK starts final-stage tests on severe asthma drug and more... |
| 2012-10-29 00:00 | | 2012's Best Pharmaceutical Stock and more... |
| 2012-10-28 00:00 | | Forest Laboratories, Inc. Announces Settlement Agreement with Hetero Labs Ltd. in BYSTOLIC?ë?£Ôö£éÔö¼?½ Patent Litigation and more... |
| 2012-10-27 12:00 | | Merck 3Q profit up 2 pct despite sales decline and more... |
| 2012-10-26 12:00 | | How Big A Dividend Will Abbott Pay After It Splits? and more... |
| 2012-10-26 00:00 | | Drugmaker Boehringer settles marketing claim for $95 mln and more... |
| 2012-10-25 12:00 | | Celgene Earnings Beat Estimates; Raises EPS Guidance and more... |
| 2012-10-25 00:00 | | Detailed data supports Actelion's big lung drug hope and more... |
| 2012-10-24 12:00 | | Bristol-Myers results lag as Plavix sales evaporate and more... |
| 2012-10-24 00:00 | | Amgen 3rd quarter profit higher, raises 2012 forecast and more... |
| 2012-10-23 12:00 | | Merck Third Quarter Earnings Preview and more... |
| 2012-10-23 00:00 | | FDA Lightens Up on Obesity Drugs and more... |
| 2012-10-22 12:00 | | Pfizer to Pay as Much as $700 Million for ADHD Drug and more... |
| 2012-10-21 12:00 | | Paladin Announces Agreement for Novel OTC Product to Treat Cold Sores and more... |
| 2012-10-21 00:00 | | IrelandâÔö£é?öé??Ôö£é?ö?ñós pharmaceutical industry and government agree on three year price of drugs saving $131 million and more... |
| 2012-10-20 12:00 | | Savient Receives Positive CHMP Opinion for Krystexxa Approval in the EU and more... |
| 2012-10-20 00:00 | | Novo's long-acting insulin degludec takes big step to megamarket status and more... |
| 2012-10-19 12:00 | | Top 10 Pharma Layoffs of 2012 and more... |
| 2012-10-19 00:00 | | BioCryst, Presidio Merger Creates Yet Another Competitor in the HCV Segment and more... |
| 2012-10-18 00:00 | | Cyclacel Heats Up On Clinical Trial Progression and more... |
| 2012-10-17 12:00 | | Abbott 3rd-qtr profit tops view, but sales disappoint |
| 2012-10-17 00:00 | | Nobel Prize Validates Recent Stem Cell Headlines and more... |
| 2012-10-16 12:00 | | Novartis Drug Diovan Retains 69% of Prescriptions in U.S. and more... |
| 2012-10-16 00:00 | | AstraZeneca Expands R&D in China to Boost Drug Discovery and more... |
| 2012-10-15 12:00 | | Forbes Earnings Preview: Abbott Laboratories and more... |
| 2012-10-14 12:00 | | Will Expedited Approval Spell Fat Profits for Drug Makers? and more... |
| 2012-10-14 00:00 | | United States : White & Case Secures Victory in AndroGel Antitrust Class Actions and more... |
| 2012-10-13 00:00 | | Vertex Gets Uneasy On Mixed Clinical Trial Results and more... |
| 2012-10-12 12:00 | | Pfizer names top execs for animal-health spinoff and more... |
| 2012-10-12 00:00 | | Here's Why Nektar Therapeutics's Latest Report Might Worry You and more... |
| 2012-10-11 12:00 | | Will GlaxoSmithKline's transparency pledge force pharma rivals to open up? and more... |
| 2012-10-11 00:00 | | Idenix: Is This Hepatitis-C Company a Bargain or a Bust? and more... |
| 2012-10-10 12:00 | | Former Synthes Execs Excluded From Federal Healthcare Programs and more... |
| 2012-10-10 00:00 | | Savient Pharmaceuticals May Continue To Run Higher and more... |
| 2012-10-09 12:00 | | NuPathe to cut half its jobs to conserve cash and more... |
| 2012-10-09 00:00 | | Lilly Backs Broad Diabetes Range to Challenge Rivals and more... |
| 2012-10-08 12:00 | | Five More Years of Patent Protection, and Revenue, for Spectrum Pharmaceuticals and more... |
| 2012-10-08 00:00 | | 90% of Pharmaceutical Professionals See Positive Business Environment in Advance of CPhI Worldwide 2012 - the Leading Gl... and more... |
| 2012-10-07 00:00 | | Healthcare Business Review: Watson Gets EU Approval, StrykerâÔö£é?öé??Ôö£é?ö?ñós Bad News and more... |
| 2012-10-06 00:00 | | Acadia Pharmaceuticals - Breaking Out For A Second Leg Up and more... |
| 2012-10-05 12:00 | | FTC Asks Supreme Court To Review Pay To Delay and more... |
| 2012-10-04 12:00 | | AllerganâÔö£é?öé??Ôö£é?ö?ñós Botox Shot Helps Overactive Bladder in Women and more... |
| 2012-10-04 00:00 | | Bristol-Myers, Sanofi revamp Plavix sales alliance and more... |
| 2012-10-03 12:00 | | Reconsidering Zalicus And Antares In Light Of Shakeups and more... |
| 2012-10-03 00:00 | | Lundbeck, Takeda seek U.S. approval for antidepressant and more... |
| 2012-10-02 12:00 | | 3 Giant Leaps for MannKind and more... |
| 2012-10-02 00:00 | | AstraZeneca Suspends The Buyback: Let The M&A Speculation Commence and more... |
| 2012-10-01 12:00 | | Aveo Oncology reports results of exploratory Phase 2 study of ficlatuzumab and more... |
